HK1202243A1 - Methods for improving cognitive function and decreasing heart rate - Google Patents
Methods for improving cognitive function and decreasing heart rateInfo
- Publication number
- HK1202243A1 HK1202243A1 HK15102730.4A HK15102730A HK1202243A1 HK 1202243 A1 HK1202243 A1 HK 1202243A1 HK 15102730 A HK15102730 A HK 15102730A HK 1202243 A1 HK1202243 A1 HK 1202243A1
- Authority
- HK
- Hong Kong
- Prior art keywords
- methods
- heart rate
- cognitive function
- improving cognitive
- decreasing heart
- Prior art date
Links
Classifications
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/21—Esters, e.g. nitroglycerine, selenocyanates
- A61K31/215—Esters, e.g. nitroglycerine, selenocyanates of carboxylic acids
- A61K31/22—Esters, e.g. nitroglycerine, selenocyanates of carboxylic acids of acyclic acids, e.g. pravastatin
- A61K31/23—Esters, e.g. nitroglycerine, selenocyanates of carboxylic acids of acyclic acids, e.g. pravastatin of acids having a carboxyl group bound to a chain of seven or more carbon atoms
- A61K31/232—Esters, e.g. nitroglycerine, selenocyanates of carboxylic acids of acyclic acids, e.g. pravastatin of acids having a carboxyl group bound to a chain of seven or more carbon atoms having three or more double bonds, e.g. etretinate
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/185—Acids; Anhydrides, halides or salts thereof, e.g. sulfur acids, imidic, hydrazonic or hydroximic acids
- A61K31/19—Carboxylic acids, e.g. valproic acid
- A61K31/20—Carboxylic acids, e.g. valproic acid having a carboxyl group bound to a chain of seven or more carbon atoms, e.g. stearic, palmitic, arachidic acids
- A61K31/202—Carboxylic acids, e.g. valproic acid having a carboxyl group bound to a chain of seven or more carbon atoms, e.g. stearic, palmitic, arachidic acids having three or more double bonds, e.g. linolenic
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
- A61P25/28—Drugs for disorders of the nervous system for treating neurodegenerative disorders of the central nervous system, e.g. nootropic agents, cognition enhancers, drugs for treating Alzheimer's disease or other forms of dementia
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P9/00—Drugs for disorders of the cardiovascular system
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P9/00—Drugs for disorders of the cardiovascular system
- A61P9/06—Antiarrhythmics
Landscapes
- Health & Medical Sciences (AREA)
- Pharmacology & Pharmacy (AREA)
- Veterinary Medicine (AREA)
- Public Health (AREA)
- Chemical & Material Sciences (AREA)
- General Health & Medical Sciences (AREA)
- Medicinal Chemistry (AREA)
- Animal Behavior & Ethology (AREA)
- Life Sciences & Earth Sciences (AREA)
- Engineering & Computer Science (AREA)
- Bioinformatics & Cheminformatics (AREA)
- General Chemical & Material Sciences (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- Chemical Kinetics & Catalysis (AREA)
- Organic Chemistry (AREA)
- Epidemiology (AREA)
- Neurology (AREA)
- Biomedical Technology (AREA)
- Neurosurgery (AREA)
- Cardiology (AREA)
- Heart & Thoracic Surgery (AREA)
- Emergency Medicine (AREA)
- Hospice & Palliative Care (AREA)
- Psychiatry (AREA)
- Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
- Medicinal Preparation (AREA)
- Medicines Containing Plant Substances (AREA)
Applications Claiming Priority (2)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
US14931009P | 2009-02-02 | 2009-02-02 | |
US18354809P | 2009-06-02 | 2009-06-02 |
Publications (1)
Publication Number | Publication Date |
---|---|
HK1202243A1 true HK1202243A1 (en) | 2015-09-25 |
Family
ID=42041547
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
HK15102730.4A HK1202243A1 (en) | 2009-02-02 | 2015-03-17 | Methods for improving cognitive function and decreasing heart rate |
Country Status (8)
Country | Link |
---|---|
US (2) | US20100203123A1 (xx) |
EP (2) | EP2939671A1 (xx) |
JP (5) | JP2012516852A (xx) |
CN (3) | CN108324706A (xx) |
AU (2) | AU2016201382A1 (xx) |
CA (1) | CA2751275A1 (xx) |
HK (1) | HK1202243A1 (xx) |
WO (1) | WO2010088700A1 (xx) |
Families Citing this family (13)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
US8207363B2 (en) | 2009-03-19 | 2012-06-26 | Martek Biosciences Corporation | Thraustochytrids, fatty acid compositions, and methods of making and uses thereof |
WO2011006144A1 (en) * | 2009-07-10 | 2011-01-13 | Martek Biosciences Corporation | Methods of treating and preventing neurological disorders using docosahexaenoic acid |
EP2709611A4 (en) * | 2011-05-19 | 2014-10-29 | Univ California | THERAPEUTIC FOOD AGAINST COGNITIVE REMOVAL |
US20130084272A1 (en) * | 2011-09-29 | 2013-04-04 | Philippe Perrin | Compositions, kits and methods for nutritional supplementation with twelve carbon chain fatty acids and twelve carbon chain acylglycerols |
US8168611B1 (en) | 2011-09-29 | 2012-05-01 | Chemo S.A. France | Compositions, kits and methods for nutrition supplementation |
BR112015023088A2 (pt) * | 2013-03-15 | 2017-11-21 | Genspera Inc | método para preparar um composto, e, composto |
KR102314507B1 (ko) | 2013-12-20 | 2021-10-18 | 마라 리뉴어블즈 코퍼레이션 | 미생물로부터 오일을 회수하는 방법 |
TR201503136A2 (tr) * | 2015-03-16 | 2016-09-21 | Sanovel Ilac Sanayi Ve Ticaret Anonim Sirketi | Dronedaron ve esansiyel yağ asitlerinin farmasötik kompozisyonları. |
US10851395B2 (en) | 2016-06-10 | 2020-12-01 | MARA Renewables Corporation | Method of making lipids with improved cold flow properties |
JP7101087B2 (ja) * | 2018-09-05 | 2022-07-14 | 株式会社 伊藤園 | 軽度認知障害に対する緑茶成分の有効性評価方法 |
FR3092968B1 (fr) * | 2019-02-22 | 2021-05-21 | Microphyt | Complement alimentaire |
WO2021022340A1 (en) * | 2019-08-08 | 2021-02-11 | Swinburne University Of Technology | Uses of long-chain polyunsaturated fatty acids |
AU2022208429A1 (en) * | 2021-01-15 | 2023-07-20 | Cambridge Cognition Limited | Methods and systems of identifying individuals for perioperative neurocognitive disorder and/or post-viral cognitive impairment |
Family Cites Families (22)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
US5407957A (en) | 1990-02-13 | 1995-04-18 | Martek Corporation | Production of docosahexaenoic acid by dinoflagellates |
US20050027004A1 (en) * | 1993-06-09 | 2005-02-03 | Martek Biosciences Corporation | Methods of treating senile dementia and Alzheimer's diseases using docosahexaenoic acid and arachidonic acid compositions |
EP0707487B1 (en) * | 1993-06-09 | 2004-04-14 | Martek Biosciences Corporation | Methods and pharmaceutical compositions useful for treating neurological disorders |
ES2135756T3 (es) | 1994-08-16 | 1999-11-01 | Frische Gmbh | Procedimiento para la obtencion de productos nativos no solubles en agua a partir de mezclas de sustancias con ayuda de la fuerza centrifuga. |
WO1996033263A1 (fr) * | 1995-04-17 | 1996-10-24 | JAPAN, represented by DIRECTOR-GENERAL OF AGENCY OF INDUSTRIAL SCIENCE AND TECHNOLOGY | Nouveaux micro-organismes capables de produire des acides gras hautement insatures et procede de production d'acides gras hautement insatures utilisant ces micro-organismes |
JP3985035B2 (ja) * | 1995-09-14 | 2007-10-03 | 独立行政法人産業技術総合研究所 | (n−6)系ドコサペンタエン酸含有油脂ならびに該油脂の製造方法および用途 |
WO2000050547A1 (en) | 1999-02-26 | 2000-08-31 | Monsanto Company | Process for separating a triglyceride comprising a docosahexaenoic acid residue from a mixture of triglycerides |
US6395778B1 (en) * | 2000-01-11 | 2002-05-28 | Omegatech, Inc. | Process for making an enriched mixture of polyunsaturated fatty acid esters |
KR20140079870A (ko) | 2000-01-19 | 2014-06-27 | 마텍 바이오싸이언스스 코포레이션 | 무용매 추출 방법 |
ATE395835T1 (de) | 2000-04-12 | 2008-06-15 | Westfalia Separator Gmbh | Verfahren zur fraktionierung von öl- und polar lipid-enthaltenden rohstoffen |
MXPA03010467A (es) | 2001-05-14 | 2004-12-06 | Martek Biosciences Boulder Corp | Produccion y uso de una fraccion polar rica en lipidos que contienen acido estearidonico y acido gama-linolenico proviniente de semillas y microbios. |
EP1392623A4 (en) | 2001-05-14 | 2005-05-04 | Martek Biosciences Corp | PREPARATION AND USE OF A POLAR LIPID RICH FRACTION CONTAINING HIGHLY UNSATURATED OMEGA-3 AND / OR OMEGA-6 FATTY ACIDS FROM MICROBES, SEEDS OF GENETICALLY MODIFIED PLANTS AND MARINE ORGANISMS |
AU2002320251A1 (en) * | 2001-07-05 | 2003-01-21 | Vital Basics, Inc. | Compositions for improving mental performance |
ES2391381T3 (es) | 2002-05-03 | 2012-11-23 | Martek Biosciences Corporation | Lípidos de alta calidad y métodos para su producción mediante liberación enzimática a partir de biomasa |
EP1845999A4 (en) * | 2005-01-24 | 2010-09-22 | Pronova Biocare As | USE OF A DHA-CONTAINING FATTY ACID COMPOSITION FOR THE PRODUCTION OF A PHARMACEUTICAL OR FOOD PRODUCT FOR THE TREATMENT OF AMYLOSIS RELATED DISEASES |
US8324276B2 (en) * | 2005-01-24 | 2012-12-04 | Pronova Biopharma Norge As | Fatty acid composition for treatment of alzheimer's disease and cognitive dysfunction |
WO2006116755A2 (en) * | 2005-04-28 | 2006-11-02 | Trustees Of Tufts College | Synergitic effects of docosahexaenoic acid (dha) and carotenoid absorption of cognitive function |
EP3090740A1 (en) * | 2005-05-23 | 2016-11-09 | Massachusetts Institute of Technology | Compositions comprising eicosapentaenoic acid for improving cognitive function |
KR101965124B1 (ko) * | 2005-07-08 | 2019-04-02 | 디에스엠 아이피 어셋츠 비.브이. | 치매 및 치매-전단계와 관련된 용태의 치료를 위한 다중불포화 지방산 |
WO2009002145A1 (en) * | 2007-06-26 | 2008-12-31 | N.V. Nutricia | Lipid composition for improving function of brain functioning |
JP2010532418A (ja) * | 2007-06-29 | 2010-10-07 | マーテック バイオサイエンシーズ コーポレーション | 多価不飽和脂肪酸のエステルの製造方法および精製方法 |
WO2011006144A1 (en) * | 2009-07-10 | 2011-01-13 | Martek Biosciences Corporation | Methods of treating and preventing neurological disorders using docosahexaenoic acid |
-
2010
- 2010-02-02 CN CN201810349154.XA patent/CN108324706A/zh active Pending
- 2010-02-02 CA CA2751275A patent/CA2751275A1/en not_active Abandoned
- 2010-02-02 JP JP2011548414A patent/JP2012516852A/ja not_active Withdrawn
- 2010-02-02 WO PCT/US2010/022952 patent/WO2010088700A1/en active Application Filing
- 2010-02-02 CN CN2010800157224A patent/CN102365087A/zh active Pending
- 2010-02-02 EP EP15162676.9A patent/EP2939671A1/en not_active Withdrawn
- 2010-02-02 EP EP10703592A patent/EP2391361A1/en not_active Withdrawn
- 2010-02-02 US US12/699,009 patent/US20100203123A1/en not_active Abandoned
- 2010-02-02 CN CN201410152946.XA patent/CN104042600A/zh active Pending
-
2012
- 2012-12-13 US US13/713,980 patent/US20130172412A1/en not_active Abandoned
-
2015
- 2015-03-17 HK HK15102730.4A patent/HK1202243A1/xx unknown
- 2015-03-20 JP JP2015057637A patent/JP2015143248A/ja active Pending
-
2016
- 2016-03-03 AU AU2016201382A patent/AU2016201382A1/en not_active Abandoned
-
2017
- 2017-10-10 AU AU2017245327A patent/AU2017245327A1/en not_active Abandoned
-
2018
- 2018-04-05 JP JP2018073345A patent/JP2018104477A/ja active Pending
-
2019
- 2019-12-27 JP JP2019238726A patent/JP2020050675A/ja active Pending
-
2022
- 2022-02-17 JP JP2022023007A patent/JP2022059063A/ja not_active Withdrawn
Also Published As
Publication number | Publication date |
---|---|
AU2017245327A1 (en) | 2017-11-02 |
US20130172412A1 (en) | 2013-07-04 |
CN102365087A (zh) | 2012-02-29 |
JP2020050675A (ja) | 2020-04-02 |
CA2751275A1 (en) | 2010-08-05 |
EP2939671A1 (en) | 2015-11-04 |
WO2010088700A1 (en) | 2010-08-05 |
CN108324706A (zh) | 2018-07-27 |
JP2015143248A (ja) | 2015-08-06 |
JP2012516852A (ja) | 2012-07-26 |
EP2391361A1 (en) | 2011-12-07 |
AU2010207929A1 (en) | 2011-09-22 |
JP2022059063A (ja) | 2022-04-12 |
JP2018104477A (ja) | 2018-07-05 |
AU2016201382A1 (en) | 2016-03-24 |
US20100203123A1 (en) | 2010-08-12 |
CN104042600A (zh) | 2014-09-17 |
Similar Documents
Publication | Publication Date | Title |
---|---|---|
HK1202243A1 (en) | Methods for improving cognitive function and decreasing heart rate | |
GB2494493B (en) | Patient interface and aspects thereof | |
GB2509641B (en) | Patient interface and aspects thereof | |
GB2530687B (en) | Patient interface and headgear | |
EP2611496A4 (en) | Methods of Treatment | |
EP2556799A4 (en) | PROCESS FOR PRODUCING TISSUE CLIPS, AND CLIPPER FOR TISSUE | |
EP2561072A4 (en) | NANOZYMES, PROCESSES FOR PRODUCING NANOZYMES, AND METHODS OF USING NANOZYMES | |
EP2578153A4 (en) | AUDIOMETER AND ASSOCIATED METHOD | |
GB0918392D0 (en) | Diagnostic and therapeutic methods | |
IL214133A0 (en) | Skin treatment | |
PT2630475T (pt) | Método de diagnóstico e tratamento | |
GB0912744D0 (en) | Methods and uses | |
EP2470022A4 (en) | COMPOUNDS AND METHODS | |
GB2467764B (en) | Attachment means and methods | |
GB0909380D0 (en) | Method and use | |
EP2654742A4 (en) | PROCESS FOR IMPROVING COGNITIVE FUNCTION | |
GB0903348D0 (en) | Compounds and methods relating thereto | |
EP2496143A4 (en) | HEART RATE MONITOR | |
EP2440238A4 (en) | Methods of Treatment | |
IL220242A0 (en) | Methods of improving cognitive functions | |
GB201013139D0 (en) | An improved bed and bath | |
GB201008694D0 (en) | An improved bed and bath | |
GB201018097D0 (en) | Diagnostic method and treatment | |
GB0920904D0 (en) | Uses and methods |